Seleniso has been covered by medical insurance, reducing the patient’s treatment burden!

Selinexor (Selinexor), a powerful tool for the treatment of relapsed and refractory multiple myeloma, brings new hope especially to patients who have poor response to traditional chemotherapy and immunotherapy. Clinical studies have shown that selinesol can significantly improve patients' progression-free survival, effectively improve their quality of life, and provide strong support for slowing down cancer progression by precisely interfering with the proliferation mechanism of cancer cells. At the same time, its therapeutic potential in areas such as lymphoma and acute myeloid leukemia (AML) is also being deeply explored.

Fortunately, Seleniso has been successfully launched in the Chinese market and has been included in medical insurance. This move means that many patients can reduce their drug cost burden through the medical insurance system, making this highly effective treatment more accessible. In China, the selling price of Seleniso ranges from RMB 5,000 to more than RMB 10,000 per box. The specific price and medical insurance reimbursement ratio may vary depending on the region and hospital. Patients only need to consult the local hospital pharmacy to obtain detailed price information and medical insurance reimbursement policies, allowing them to make more informed treatment choices.

Compared with foreign countries, the price of Seleniso is slightly higher in the country. In particular, the price of the Lao version of the generic Selenisor drug is only more than 2,000 yuan per box, which has a significant price advantage compared with the domestic original drug. However, when choosing to purchase generic drugs, patients must ensure that the drugs are legal and quality-reliable. It is recommended to purchase through formal channels and reliable drug suppliers to avoid potential risks.

in the country, the purchasing channels for Seleniso are relatively convenient. Patients can easily obtain it through hospital pharmacies or drug retailers. At the same time, since Seleniso has been included in medical insurance, patients can enjoy certain reimbursement benefits with their medical insurance cards, further reducing the burden of treatment. For patients who are considering purchasing overseas, especially those who choose Laos version of generic drugs, they must confirm the legality of the purchasing method and the quality and safety of the drugs. Choosing formal drug import channels and reliable drug suppliers is the key to ensuring drug quality and safety.

xa0

Reference materials:

National Medical Products Administration (NMPA) official website. Seleniso approval information:https://www.nmpa.gov.cn